Previous 10 | Next 10 |
home / stock / vphif / vphif news
VALEO PHARMA TO HOST FIRST QUARTER 2022 RESULTS CONFERENCE CALL / WEBCAST AND ATTEND THE 8TH ANNUAL ALPHANORTH CAPITAL CONFERENCE Canada NewsWire MONTREAL , March 17, 2022 /CNW Telbec/ - Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " o...
VALEO PHARMA REPORTS RECORD ANNUAL REVENUES FOR FISCAL 2021 Canada NewsWire Record revenues in 2021 of $13.6 million , up 81% over 2020 Annual Gross Margins for 2021, $4 Million , up 186% over 2020 Q4-21 revenues of $3.4 million , up 53% o...
VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR ENERZAIR® BREEZHALER® AND ATECTURA® BREEZHALER® IN ONTARIO, MANITOBA AND NEW BRUNSWICK Canada NewsWire Atectura and Enerzair also now reimbursed by the Non-Insured Health Benefits ("NIHB") program ...
VALEO PHARMA TO HOST FOURTH QUARTER AND YEAR-END 2021 RESULTS CONFERENCE CALL / WEBCAST Canada NewsWire MONTREAL , Feb. 21, 2022 /CNW Telbec/ - Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmace...
VALEO PHARMA'S HESPERCO™ NOW AVAILABLE AT LOBLAWS, HESPERIDIN COVID-19 CLINICAL TRIAL RESULTS SUBMITTED FOR PUBLICATION Canada NewsWire Hesperco now available in approximately 300 stores under the Loblaws banners Clinical study yields encouraging resul...
VALEO PHARMA OBTAINS PUBLIC REIMBURSEMENT FOR ENERZAIR® BREEZHALER® AND ATECTURA® BREEZHALER® IN QUEBEC AND NOVA SCOTIA Canada NewsWire Public reimbursement now includes Alberta , Quebec and Nova Scotia , representing approximately 37%...
VALEO PHARMA CLOSES PREVIOUSLY ANNOUNCED UPSIZED $15 MILLION BOUGHT DEAL PRIVATE PLACEMENT AND CONCURRENT $10 MILLION PRIVATE PLACEMENT FROM INVESTISSEMENT QUEBEC Canada NewsWire NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS MONTREAL, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Valeo Pharma Inc. ( CSE:VPH, OTCQB: VP...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS MONTREAL, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Valeo Pharma Inc. ( CSE:VPH, OTCQB...
Valeo Pharma Obtains Public Reimbursement for Redesca™ and Redesca Hp™ in Quebec Canada NewsWire Public reimbursement coverage reaches 9 Provinces in Canada Canadian private health plan coverage now exceeding 90% MONTREAL , Nov...
News, Short Squeeze, Breakout and More Instantly...
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE Canada NewsWire MONTREAL , June 18, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical compan...
(NewsDirect) Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million rec...
VALEO PHARMA ANNOUNCES RESTRUCTURING OF COMMERCIAL FIELD OPERATIONS TO SUPPORT PATH TO PROFITABILITY Canada NewsWire Changes to respiratory business unit to generate more than $5 million in annual savings Follows previously announced cost saving measures exce...